08-06-2026 01:35 via rocketnews.com

The Wegovy pill is still dominating the GLP-1 pill market

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Article Attribution | Read More at Article Source
The post The Wegovy pill is still dominating the GLP-1 pill market appeared first on RocketNews.

Read more »

Short-Term Analysis for Oil, Gold, and EURUSD for 08.06.2026

Short-Term Analysis for Oil, Gold, and EURUSD for 08.06.2026

Greenback Surges After Strong US Jobs Data. Forecast as of 08.06.2026

Greenback Surges After Strong US Jobs Data. Forecast as of 08.06.2026

Short-Term Analysis for BTCUSD, XRPUSD, and ETHUSD for 08.06.2026

Short-Term Analysis for BTCUSD, XRPUSD, and ETHUSD for 08.06.2026

U.S. stock futures mixed, oil prices surge as new attacks threaten the cease-fire with Iran

S&P 500 companies can’t stop talking about higher oil prices. But few say they’ll actually hurt profits.

These are the market’s new hot stocks as investors flee from tech

A new wave of weight-loss therapies aims to be better than today’s GLP-1s

S&P 500 sees $1.8 trillion wipeout, Nasdaq tallies biggest point drop on record: What investors need to know about Friday’s selloff

‘He’s taking advantage of me’: My husband won’t sell his home so we can combine our finances and live in comfort. Am I unreasonable?

Tired of nausea or taking a GLP-1 pill every day? These experimental drugs could be better than Zepbound and Wegovy.

Most robo-advisers will never profit from Wall Street’s AI-generated stock picks

Busted AI budgets at Uber, Microsoft and Nvidia spur hiring — because human workers are cheaper

Can SpaceX live up to Wall Street’s multitrillion-dollar hype?

Bitcoin is suffering from an ‘attention’ deficit, as momentum traders have moved on